SARS-CoV-2 seroprevalence in COVID-19 hotspots

Lancet. 2020 Aug 22;396(10250):514-515. doi: 10.1016/S0140-6736(20)31482-3. Epub 2020 Jul 6.

Authors

Isabella Eckerle¹, Benjamin Meyer²

Affiliations

¹ Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland. Electronic address: [email protected].
² Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.

No abstract available

Publication types

Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
Prevalence
SARS-CoV-2
Seroepidemiologic Studies
Spain